Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Hair loss in older men is linked to higher rates of diabetes and high blood pressure.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

The normal range for the hair pull test is 2 hairs or fewer, and washing or brushing hair before the test does not affect the results.

Drug repurposing is a faster, cheaper way to develop new treatments using existing drugs.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Minoxidil in breast milk may harm nursing infants.

Anabolic steroid users may face higher risk of severe COVID-19.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

Older adults still engage in sexual activities but face challenges like health issues and lack of professional support, highlighting the need for better healthcare provider education and research on sexual fulfillment in old age.

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

Possible link between androgens and COVID-19 severity; more research needed.

Men had worse COVID-19 outcomes than women in New York City.

Some alopecia treatments might help treat COVID-19, but more research is needed.